1176378

Akcea Therapeutics, Inc. — FEI 3015007621

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Carlsbad, CA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)